Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EXENATIDE
- Pharmacogenomics of GLP1 Receptor Agonists
- Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes
- Exenatide for Smoking Cessation and Prevention of Weight Gain
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAP-SVD)
- A Phase III Trial to Determine the Efficacy and Safety of Presendin in IIH
- Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
- Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
- Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
- Degludec Glargine U300 Hospital Study
- Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.
- Exenatide for Treating Cocaine Use Disorder
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- Efficacy of Liraglutide Therapy in Patients With IPAA
- Brain Activation and Satiety in Children 2
- Exenatide Once-weekly as a Treatment for Multiple System Atrophy
- Proof of Concept Study in Patients With Short Bowel Syndrome
- Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes
- Exenatide Treatment in Parkinson's Disease
- Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.
- SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
- Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
- A Study With NLY01 in Subjects With Type 2 Diabetes
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
- Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
- Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
- Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
- A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Effects of Exenatide on Motor Function and the Brain
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
- The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
- Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
- Research of Exenatide for Overweight/Obese PCOS Patients With IGR
- Can Exenatide Prevent the Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
- Once Weekly GLP-1 in Persons With Spinal Cord Injury
- Trial of EXenatide in Acute Ischaemic Stroke
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
- Effect of Exenatide on Cortisol Secretion
- The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
- Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Exenatide Once Weekly for Smoking Cessation
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
- GLP-1/Basal Insulin Combination Therapy
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
- Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Effect of Liraglutide on Clock Genes
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
- Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
- Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
- Diabetes Islet Preservation Immune Treatment
- The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
- Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
- Effects of Glucagon Like Peptide-1 on No-reflow
- The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
- Saxagliptin and Cardiac Structure and Function
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
- Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
- Incretin-based Drugs and the Risk of Heart Failure
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
- Sitagliptin and Endothelial Dysfunction
- COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
- Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
- A Comparison of Exenatide and Insulin Glargine
- Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
- GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
- Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
- Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
- Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
- GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
- Liver and Fat Regulation in Overweight Adolescent Girls
- The Differential Effects of Diabetes Therapy on Inflammation
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
- Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
- Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
- Safety Evaluation of Adverse Reactions in Diabetes
- Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
- Exenatide and Weight Loss for Diabetes Prevention
- Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- Intravenous Exenatide in Patients With Acute Brain Injury
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Trial of Exenatide for Parkinson's Disease
- Exenatide for Stress Hyperglycemia
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- Exenatide for Myocardial Protection During Reperfusion Study
- A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
- An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
- Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
- Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
- Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
- Extension Study for 2993-112
- Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
- Liraglutide in Type 1 Diabetes
- Weight Loss With Exenatide Treatment
- Acute Effect of Exenatide on Brain Glucose Metabolism
- Myocardial Protection of Exenatide in AMI
- DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
- Pharmacology of Exenatide in Pediatric Sepsis
- Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
- Sitagliptin Dose Determination Study
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes
- Impact of Exenatide on Sleep Duration
- Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
- Changes in Bone Turnover With Increased Incretin Hormone Exposure
- Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- GLP Analogs for Diabetes in Wolfram Syndrome Patients
- A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- New Onset Type 1 Diabetes: Role of Exenatide
- A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
- Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
- Exenatide in Extreme Pediatric Obesity
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
- Exeantide in Type 2 Diabetes on Insulin
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
- Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
- Impact of Exenatide on Sleep in Type 2 Diabetes
- Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
- A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
- Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
- A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- A Study in Participants With Type 2 Diabetes Mellitus
- Effects of Exenatide on Hypothalamic Obesity
- Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
- A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
- Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
- A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
- Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
- Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
- A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
- GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
- Intravenous Exenatide (Byetta) During Surgery
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
- The Effects of Exenatide After Gastric Restriction
- A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Evaluation of Exenatide in Patients With Diabetic Neuropathy
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
- Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
- Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
- Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
- Role of Exenatide in NASH-a Pilot Study
- Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
- Bioenergetic Alterations After Exenatide Administration
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- GLP1R Polymorphisms and Response to GLP1
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
- The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
- A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
- An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
- Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
- Role of Exenatide in Type 1 Diabetes
- Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
- Safety and Efficacy of Exenatide as Monotherapy
- Effect on Weight Loss of Exenatide Versus Placebo
- A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
- Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
- The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
- Exenatide and Metformin Therapy in Overweight Women With PCOS
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
- Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
- Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
- In-patient Study in Patients With Type 2 Diabetes Mellitus
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Clinical trials list
click for details